Wine and Cardiovascular Health

Circulation

Volumn 136, Issue 15, 2017, Pages 1434-1448

  Haseeb, Sohaib ^a   Alexander, Bryce ^a   Baranchuk, Adrian ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

alcohol drinking; French Paradox; myocardial ischemia; polyphenols; wine

Indexed keywords

ALCOHOL; FLAVONOID; POLYPHENOL; QUERCETIN; RESVERATROL; CARDIOTONIC AGENT;

ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ATRIAL FIBRILLATION; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MORTALITY; CHEMICAL COMPOSITION; CLINICAL PRACTICE; DIETARY INTAKE; DRINKING BEHAVIOR; EVIDENCE BASED MEDICINE; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RED WINE; REVIEW; WINE; ANIMAL; MYOCARDIAL ISCHEMIA;

ALCOHOL DRINKING; ANIMALS; CARDIOTONIC AGENTS; HUMANS; MYOCARDIAL ISCHEMIA; POLYPHENOLS; PREVALENCE; WINE;

EID: 85031708892     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.030387     Document Type: Review

References (100)

1. Phillips R. Alcohol: A History. Chapel Hill, NC: UNC Press Books; 2014.
2. Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, Stampfer MJ. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet Lond Engl. 1991;338:464-468. doi: 10.1016/0140-6736(91)90542-W.
3. St Leger AS, Cochrane AL, Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet. 1979;1:1017-1020. doi:10.1016/S0140-6736(79)92765-X.
4. Criqui MH, Ringel BL. Does diet or alcohol explain the French paradox? Lancet. 1994;344:1719-1723. doi:10.1016/S0140-6736(94)92883-5.
5. Grønbaek M, Deis A, Sørensen TI, Becker U, Schnohr P, Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. BMJ. 1995;310:1165-1169. doi: 10.1136/bmj.310.6988.1165.
6. Pignatelli P, Ghiselli A, Buchetti B, Carnevale R, Natella F, Germanò G, Fimognari F, Di Santo S, Lenti L, Violi F. Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. Atherosclerosis. 2006;188:77-83. doi: 10.1016/j.atherosclerosis.2005.10.025.
7. Iriti M, Varoni EM. Cardioprotective effects of moderate red wine consumption: polyphenols vs. ethanol. J Appl Biomed. 2014;12:193-202. doi:10.1016/j.jab.2014.09.003.
8. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992;339:1523-1526. doi:10.1016/0140-6736(92)91277-F.
9. Kris-Etherton P, Eckel RH, Howard BV, Jeor SS, Bazzarre TL. Lyon Diet Heart Study. Circulation. 2001;103:1823-1825. doi:10.1161/01.CIR.103. 13.1823.
10. US Department of Health and Human Services. Dietary Guidelines for Americans 2015-2020. New York, NY: Skyhorse Publishing Inc; 2017.
11. Soobrattee MA, Neergheen VS, Luximon-Ramma A, Aruoma OI, Bahorun T. Phenolics as potential antioxidant therapeutic agents: mechanism and actions. Mutat Res. 2005;579:200-213. doi: 10.1016/j.mrfmmm. 2005.03.023.
12. Rehm J, Room R, Monteiro M, Gmel G, Graham K, Rehn N, Sempos CT, Jernigan D. Alcohol as a risk factor for global burden of disease. Eur Addict Res. 2003;9:157-164. doi: 10.1159/000072222.
13. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373:2223-2233. doi: 10.1016/S0140-6736(09)60746-7.
14. Kalinowski A, Humphreys K. Governmental standard drink definitions and low-risk alcohol consumption guidelines in 37 countries. Addiction. 2016;111:1293-1298. doi: 10.1111/add.13341.
15. Kloner RA, Rezkalla SH. To drink or not to drink? That is the question. Circulation. 2007;116:1306-1317. doi: 10.1161/CIRCULATIONAHA. 106.678375.
16. Mongan D, Long J. Standard drink measures throughout Europe; peoples' understanding of standard drinks and their use in drinking guidelines, alcohol surveys and labelling. Dublin, Ireland: Health Research Board; 2015.
17. Kerr WC, Stockwell T. Understanding standard drinks and drinking guidelines. Drug Alcohol Rev. 2012;31:200-205. doi: 10.1111/j.1465-3362.2011.00374.x.
18. Babor TF, Higgins-Biddle JC. Brief Intervention for Hazardous and Harmful Drinking: A Manual for Use in Primary Care. Geneva, Switzerland: World Health Organization; 2001. http://apps.who.int/iris/bitstream/ 10665/67210/1/WHO-MSD-MSB-01.6b.pdf. Accessed April 6, 2017.
19. Voskoboinik A, Prabhu S, Ling LH, Kalman JM, Kistler PM. Alcohol and atrial fibrillation: a sobering review. J Am Coll Cardiol. 2016;68:2567-2576. doi: 10.1016/j.jacc.2016.08.074.
20. Brown L, Kroon PA, Das DK, Das S, Tosaki A, Chan V, Singer MV, Feick P. The biological responses to resveratrol and other polyphenols from alcoholic beverages. Alcohol Clin Exp Res. 2009;33:1513-1523. doi: 10.1111/j.1530-0277.2009.00989.x.
21. Ferrières J. The French paradox: lessons for other countries. Heart. 2004;90:107-111. doi: 10.1136/heart.90.1.107.
22. Markoski MM, Garavaglia J, Oliveira A, Olivaes J, Marcadenti A. Molecular properties of red wine compounds and cardiometabolic benefits. Nutr Metab Insights. 2016;9:51-57. doi: 10.4137/NMI.S32909.
23. Stockley C, Teissedre PL, Boban M, Di Lorenzo C, Restani P. Bioavailability of wine-derived phenolic compounds in humans: a review. Food Funct. 2012;3:995-1007. doi: 10.1039/c2fo10208k.
24. Bertelli AA. Wine, research and cardiovascular disease: instructions for use. Atherosclerosis. 2007;195:242-247. doi: 10.1016/j.atherosclerosis. 2007.04.006.
25. Covas MI, Gambert P, Fitó M, de la Torre R. Wine and oxidative stress: up-to-date evidence of the effects of moderate wine consumption on oxidative damage in humans. Atherosclerosis. 2010;208:297-304. doi: 10.1016/j.atherosclerosis.2009.06.031.
26. McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr. 2012;95:454-464. doi: 10.3945/ ajcn.111.016634.
27. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 1993;342:1007-1011. doi:10.1016/0140-6736(93)92876-U.
28. Nigdikar SV, Williams NR, Griffin BA, Howard AN. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr. 1998;68:258-265.
29. Perez-Vizcaino F, Duarte J, Andriantsitohaina R. Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic Res. 2006;40:1054-1065. doi: 10.1080/10715760600823128.
30. Mano T, Masuyama T, Yamamoto K, Naito J, Kondo H, Nagano R, Tanouchi J, Hori M, Inoue M, Kamada T. Endothelial dysfunction in the early stage of atherosclerosis precedes appearance of intimal lesions assessable with intravascular ultrasound. Am Heart J. 1996;131:231-238. doi: 10.1016/S0002-8703(96)90346-4.
31. Knekt P, Kumpulainen J, Järvinen R, Rissanen H, Heliövaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr. 2002;76:560-568.
32. Ferro-Luzzi A, Branca F. Mediterranean diet, Italian-style: prototype of a healthy diet. Am J Clin Nutr. 1995;61(6 suppl):1338S-1345S.
33. Mohamed Saleem TS. Red wine: a drink to your heart. J Cardiovasc Dis Res. 2010;1:171-176. doi: 10.4103/0975-3583.74259.
34. Manach C, Morand C, Crespy V, Demigné C, Texier O, Régérat F, Rémésy C. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett. 1998;426:331-336. doi:10.1016/S0014-5793(98)00367-6.
35. Hollman PC, vd Gaag M, Mengelers MJ, van Trijp JM, de Vries JH, Katan MB. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic Biol Med. 1996;21:703-707. doi:10.1016/0891-5849(96)00129-3.
36. Loke WM, Proudfoot JM, Hodgson JM, McKinley AJ, Hime N, Magat M, Stocker R, Croft KD. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2010;30:749-757. doi: 10.1161/ATVBAHA.109.199687.
37. Bae SC, Jung WJ, Lee EJ, Yu R, Sung MK. Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. J Am Coll Nutr. 2009;28:56-62.
38. KolchinIuN, Maksiutina NP, Balanda PP, Luǐk AI, Bulakh VN, Moǐbenko AA. [The cardioprotective action of quercetin in experimental occlusion and reperfusion of the coronary artery in dogs]. Farmakol Toksikol. 1991;54:20-23.
39. Ikizler M, Erkasap N, Dernek S, Kural T, Kaygisiz Z. Dietary polyphenol quercetin protects rat hearts during reperfusion: enhanced antioxidant capacity with chronic treatment. Anadolu Kardiyol Derg. 2007;7:404-410.
40. Bonnefont-Rousselot D. Resveratrol and cardiovascular diseases. Nutrients. 2016;8. doi:10.3390/nu8050250.
41. Smoliga JM, Baur JA, Hausenblas HA. Resveratrol and health-A comprehensive review of human clinical trials. Mol Nutr Food Res. 2011;55:1129-1141. doi: 10.1002/mnfr.201100143.
42. Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004;32:1377-1382. doi: 10.1124/dmd.104.000885.
43. Goldberg DM, Yan J, Soleas GJ. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem. 2003;36:79-87. doi:10.1016/S0009-9120(02)00397-1.
44. Soleas GJ, Yan J, Goldberg DM. Ultrasensitive assay for three polyphenols (catechin, quercetin and resveratrol) and their conjugates in biological fluids utilizing gas chromatography with mass selective detection. J Chromatogr B Biomed Sci Appl. 2001;757:161-172. doi:10.1016/S0378-4347(01)00142-6.
45. Zordoky BN, Robertson IM, Dyck JR. Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochim Biophys Acta. 2015;1852:1155-1177. doi: 10.1016/j.bbadis.2014.10.016.
46. Ruf JC, Berger JL, Renaud S. Platelet rebound effect of alcohol withdrawal and wine drinking in rats. Relation to tannins and lipid peroxidation. Arterioscler Thromb Vasc Biol. 1995;15:140-144.
47. Pikaar NA, Wedel M, van der Beek EJ, van Dokkum W, Kempen HJ, Kluft C, Ockhuizen T, Hermus RJ. Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids. Metabolism. 1987;36:538-543. doi:10.1016/0026-0495(87)90163-6.
48. Virdis A, Ghiadoni L, Taddei S. Human endothelial dysfunction: EDCFs. Pflugers Arch. 2010;459:1015-1023. doi: 10.1007/s00424-009-0783-7.
49. Gresele P, Pignatelli P, Guglielmini G, Carnevale R, Mezzasoma AM, Ghiselli A, Momi S, Violi F. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J Nutr. 2008;138:1602-1608.
50. Gillman MW, Cook NR, Evans DA, Rosner B, Hennekens CH. Relationship of alcohol intake with blood pressure in young adults. Hypertension. 1995;25:1106-1110. doi:10.1161/01.HYP.25.5.1106.
51. Araya J, Rodrigo R, Orellana M, Rivera G. Red wine raises plasma HDL and preserves long-chain polyunsaturated fatty acids in rat kidney and erythrocytes. Br J Nutr. 2001;86:189-195. doi:10.1079/BJN2001369.
52. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999;319:1523-1528. doi:10.1136/ bmj.319.7224.1523.
53. Norum RA, Lakier JB, Goldstein S, Angel A, Goldberg RB, Block WD, Noffze DK, Dolphin PJ, Edelglass J, Bogorad DD, Alaupovic P. Familial deficiency of apolipoproteins A-I and C-III and precocious coronaryartery disease. N Engl J Med. 1982;306:1513-1519. doi: 10.1056/ NEJM198206243062503.
54. Facchini F, Chen YD, Reaven GM. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care. 1994;17:115-119. doi:10.2337/diacare.17.2.115.
55. Kiechl S, Willeit J, Poewe W, Egger G, Oberhollenzer F, Muggeo M, Bonora E. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). BMJ. 1996;313:1040-1044. doi:10.1136/bmj.313.7064.1040.
56. Lazarus R, Sparrow D, Weiss ST. Alcohol intake and insulin levels. The Normative Aging Study. Am J Epidemiol. 1997;145:909-916. doi:10.1093/ oxfordjournals.aje.a009050.
57. Gul EE, Pal R, Caldwell J, Boles U, Hopman W, Glover B, Michael KA, Redfearn D, Simpson C, Abdollah H, Baranchuk A. Interatrial block and interatrial septal thickness in patients with paroxysmal atrial fibrillation undergoing catheter ablation: long-term follow-up study. Ann Noninvasive Electrocardiol. 2016;22. doi:10.1111/anec.12428.
58. Ruigómez A, Johansson S, Wallander MA, García Rodríguez LA. Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK. BMC Cardiovasc Disord. 2005;5:20. doi: 10.1186/1471-2261-5-20.
59. Planas F, Romero-Menor C, Vázquez-Oliva G, Poblet T, Navarro-López F; en representación de los investigadores del Estudio FAP de los hospitales comarcales y centros extrahospitalarios de Cataluña. [Natural history of and risk factors for idiopathic atrial fibrillation recurrence (FAP Registry)]. Rev Esp Cardiol. 2006;59:1106-1112.
60. Gould L, Reddy CV, Becker W, Oh KC, Kim SG. Electrophysiologic properties of alcohol in man. J Electrocardiol. 1978;11:219-226. doi:10.1016/ S0022-0736(78)80120-4.
61. Alexander B, MacHaalany J, Lam B, van Rooy H, Haseeb S, Kuchtaruk A, Glover B, Bayés de Luna A, Baranchuk A. Comparison of the extent of coronary artery disease in patients with versus without interatrial block and implications for new-onset atrial fibrillation. Am J Cardiol. 2017;119:1162-1165. doi: 10.1016/j.amjcard.2016.12.032.
62. Steinbigler P, Haberl R, König B, Steinbeck G. P-wave signal averaging identifies patients prone to alcohol-induced paroxysmal atrial fibrillation. Am J Cardiol. 2003;91:491-494. doi:10.1016/S0002-9149(02)03258-7.
63. Gurr MI. Wine and coronary heart disease. Lancet. 1992;340:313. doi:10.1016/0140-6736(92)92410-H.
64. Rimm EB, Klatsky A, Grobbee D, Stampfer MJ. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits. BMJ. 1996;312:731-736. doi:10.1136/ bmj.312.7033.731.
65. Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006;166:2437-2445. doi: 10.1001/archinte.166.22.2437.
66. Friedman LA, Kimball AW. Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol. 1986;124:481-489.
67. Keil U, Chambless LE, Döring A, Filipiak B, Stieber J. The relation of alcohol intake to coronary heart disease and all-cause mortality in a beer-drinking population. Epidemiology. 1997;8:150-156.
68. Grønbak M. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med. 2000;133:411. doi:10.7326/0003-4819-133-6-200009190-00008.
69. Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med. 1988;319:267-273. doi: 10.1056/NEJM198808043190503.
70. Levantesi G, Marfisi R, Mozaffarian D, Franzosi MG, Maggioni A, Nicolosi GL, Schweiger C, Silletta M, Tavazzi L, Tognoni G, Marchioli R. Wine consumption and risk of cardiovascular events after myocardial infarction: results from the GISSI-Prevenzione trial. Int J Cardiol. 2013;163:282-287. doi: 10.1016/j.ijcard.2011.06.053.
71. Klatsky AL, Armstrong MA. Alcoholic beverage choice and risk of coronary artery disease mortality: do red wine drinkers fare best? Am J Cardiol. 1993;71:467-469. doi:10.1016/0002-9149(93)90460-T.
72. Yano K, Rhoads GG, Kagan A. Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii. N Engl J Med. 1977;297:405-409. doi: 10.1056/NEJM197708252970801.
73. Kittner SJ, Garcia-Palmieri MR, Costas R Jr, Cruz-Vidal M, Abbott RD, Havlik RJ. Alcohol and coronary heart disease in Puerto Rico. Am J Epidemiol. 1983;117:538-550.
74. Klatsky AL, Armstrong MA, Friedman GD. Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers. Am J Cardiol. 1990;66:1237-1242. doi: 10.1016/0002-9149(90)91107-H.
75. Salonen JT, Puska P, Nissinen A. Intake of spirits and beer and risk of myocardial infarction and death-A longitudinal study in Eastern Finland. J Chronic Dis. 1983;36:533-543. doi: 10.1016/0021-9681(83)90131-5.
76. Fernández-Solà J. Cardiovascular risks and benefits of moderate and heavy alcohol consumption. Nat Rev Cardiol. 2015;12:576-587. doi: 10.1038/nrcardio.2015.91.
77. Ducimetiere P, Guize L, Marciniak A, Milon H, Richard J, Rufat P. Arteriographically documented coronary artery disease and alcohol consumption in French men. The CORALI Study. Eur Heart J. 1993;14:727-733. doi:10.1093/eurheartj/14.6.727.
78. Klatsky AL, Armstrong MA, Friedman GD. Alcohol and mortality. Ann Intern Med. 1992;117:646-654.
79. Mukamal KJ, Jensen MK, Grønbaek M, Stampfer MJ, Manson JE, Pischon T, Rimm EB. Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men. Circulation. 2005;112:1406-1413. doi: 10.1161/CIRCULATIONAHA.105.537704.
80. Arendt BM, Ellinger S, Kekic K, Geus L, Fimmers R, Spengler U, Müller WU, Goerlich R. Single and repeated moderate consumption of native or dealcoholized red wine show different effects on antioxidant parameters in blood and DNA strand breaks in peripheral leukocytes in healthy volunteers: a randomized controlled trial (ISRCTN68505294). Nutr J. 2005;4:33. doi: 10.1186/1475-2891-4-33.
81. Micallef M, Lexis L, Lewandowski P. Red wine consumption increases antioxidant status and decreases oxidative stress in the circulation of both young and old humans. Nutr J. 2007;6:27. doi: 10.1186/1475-2891-6-27.
82. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-952. doi: 10.1016/S0140-6736(04)17018-9.
83. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345:790-797. doi: 10.1056/NEJMoa010492.
84. Kerry NL, Abbey M. Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro. Atherosclerosis. 1997;135:93-102. doi:10.1016/S0021-9150(97)00156-1.
85. Serafini M, Maiani G, Ferro-Luzzi A. Alcohol-free red wine enhances plasma antioxidant capacity in humans. J Nutr. 1998;128:1003-1007.
86. Stein JH, Keevil JG, Wiebe DA, Aeschlimann S, Folts JD. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation. 1999;100:1050-1055. doi: 10.1161/01.CIR.100.10.1050.
87. Leikert JF, Räthel TR, Wohlfart P, Cheynier V, Vollmar AM, Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation. 2002;106:1614-1617. doi:10.1161/01.CIR.0000034445.31543.43.
88. De Curtis A, Murzilli S, Di Castelnuovo A, Rotilio D, Donati MB, De Gaetano G, Iacoviello L. Alcohol-free red wine prevents arterial thrombosis in dietary-induced hypercholesterolemic rats: experimental support for the 'French paradox.' J Thromb Haemost. 2005;3:346-350. doi: 10.1111/j.1538-7836.2005.01126.x.
89. Karatzi KN, Papamichael CM, Karatzis EN, Papaioannou TG, Aznaouridis KA, Katsichti PP, Stamatelopoulos KS, Zampelas A, Lekakis JP, Mavrikakis ME. Red wine acutely induces favorable effects on wave reflections and central pressures in coronary artery disease patients. Am J Hypertens. 2005;18(9 pt 1):1161-1167. doi: 10.1016/j.amjhyper. 2005.03.744.
90. Listl S, Jürges H, Watt RG. Causal inference from observational data. Community Dent Oral Epidemiol. 2016;44:409-415. doi: 10.1111/ cdoe.12231.
91. Kundi M. Causality and the interpretation of epidemiologic evidence. Environ Health Perspect. 2006;114:969-974. doi:10.1289/ehp.8297.
92. Zuccolo L, Holmes MV. Commentary: Mendelian randomization-inspired causal inference in the absence of genetic data. Int J Epidemiol. 2016. doi:10.1093/ije/dyw327.
93. Holmes MV, Dale CE, Zuccolo L, Silverwood RJ, Guo Y, Ye Z, Prieto-Merino D, Dehghan A, Trompet S, Wong A, Cavadino A, Drogan D, Padmanabhan S, Li S, Yesupriya A, Leusink M, Sundstrom J, Hubacek JA, Pikhart H, Swerdlow DI, Panayiotou AG, Borinskaya SA, Finan C, Shah S, Kuchenbaecker KB, Shah T, Engmann J, Folkersen L, Eriksson P, Ricceri F, Melander O, Sacerdote C, Gamble DM, Rayaprolu S, Ross OA, McLachlan S, Vikhireva O, Sluijs I, Scott RA, Adamkova V, Flicker L, Bockxmeer FM, Power C, Marques-Vidal P, Meade T, Marmot MG, Ferro JM, Paulos-Pinheiro S, Humphries SE, Talmud PJ, Mateo Leach I, Verweij N, Linneberg A, Skaaby T, Doevendans PA, Cramer MJ, van der Harst P, Klungel OH, Dowling NF, Dominiczak AF, Kumari M, Nicolaides AN, Weikert C, Boeing H, Ebrahim S, Gaunt TR, Price JF, Lannfelt L, Peasey A, Kubinova R, Pajak A, Malyutina S, Voevoda MI, Tamosiunas A, Maitland-van der Zee AH, Norman PE, Hankey GJ, Bergmann MM, Hofman A, Franco OH, Cooper J, Palmen J, Spiering W, de Jong PA, Kuh D, Hardy R, Uitterlinden AG, Ikram MA, Ford I, Hyppönen E, Almeida OP, Wareham NJ, Khaw KT, Hamsten A, Husemoen LL, Tjønneland A, Tolstrup JS, Rimm E, Beulens JW, Verschuren WM, Onland-Moret NC, Hofker MH, Wannamethee SG, Whincup PH, Morris R, Vicente AM, Watkins H, Farrall M, Jukema JW, Meschia J, Cupples LA, Sharp SJ, Fornage M, Kooperberg C, LaCroix AZ, Dai JY, Lanktree MB, Siscovick DS, Jorgenson E, Spring B, Coresh J, Li YR, Buxbaum SG, Schreiner PJ, Ellison RC, Tsai MY, Patel SR, Redline S, Johnson AD, Hoogeveen RC, Hakonarson H, Rotter JI, Boerwinkle E, de Bakker PI, Kivimaki M, Asselbergs FW, Sattar N, Lawlor DA, Whittaker J, Davey Smith G, Mukamal K, Psaty BM, Wilson JG, Lange LA, Hamidovic A, Hingorani AD, Nordestgaard BG, Bobak M, Leon DA, Langenberg C, Palmer TM, Reiner AP, Keating BJ, Dudbridge F, Casas JP; InterAct Consortium. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ. 2014;349:g4164. doi:10.1136/bmj.g4164.
94. Lawlor DA, Nordestgaard BG, Benn M, Zuccolo L, Tybjaerg-Hansen A, Davey Smith G. Exploring causal associations between alcohol and coronary heart disease risk factors: findings from a Mendelian randomization study in the Copenhagen General Population Study. Eur Heart J. 2013;34:2519-2528. doi: 10.1093/eurheartj/eht081.
95. Yun KE, Chang Y, Yun S, Davey Smith G, Ryu S, Cho S, Chung EC, Shin H, Khang Y. Alcohol and coronary artery calcification: an investigation using alcohol flushing as an instrumental variable. Int J Epidemiol. 2017;46:950-962. doi:10.1093/ije/dyw237.
96. World Health Organization. The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization; 2002. https://books.google.ca/books?hl=en&lr=&id=epuQi1PtY-cC&oi= fnd&pg=PR9&dq=WHO.+The+world+health+report+2002:+reducing+ri sks,+promoting+healthy+life.+Geneva:+World+Health+Organization,+2 002&ots=N2N6cWGgQl&sig=QPEs4uSwlfVCtNTaPopkSzxLISw. Accessed May 7, 2017.
97. Shults RA, Elder RW, Sleet DA, Nichols JL, Alao MO, Carande-Kulis VG, Zaza S, Sosin DM, Thompson RS; Task Force on Community Preventive Services. Reviews of evidence regarding interventions to reduce alcoholimpaired driving. Am J Prev Med. 2001;21(4 suppl):66-88. doi:10.1016/ S0749-3797(01)00381-6.
98. Foran HM, O'Leary KD. Alcohol and intimate partner violence: a metaanalytic review. Clin Psychol Rev. 2008;28:1222-1234. doi: 10.1016/j. cpr.2008.05.001.
99. Goldberg IJ, Mosca L, Piano MR, Fisher EA. Wine and your heart. Circulation. 2001;103:472-475. doi:10.1161/01.CIR.103.3.472.
100. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Horn LV, Winston M, Wylie-Rosett J. Diet and Lifestyle Recommendations Revision 2006. Circulation. 2006;114:82-96. doi:10.1161/CIRCULATIONAHA.106.176158.